339 related articles for article (PubMed ID: 26111247)
1. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
Jun JH; Hwang JC
JAMA Ophthalmol; 2015 Oct; 133(10):1184-6. PubMed ID: 26111247
[TBL] [Abstract][Full Text] [Related]
2. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy.
Myers SP; Dadashzadeh ER; Cheung J; Alarcon L; Kutcher M; Brown JB; Neal MD
J Trauma Acute Care Surg; 2017 Mar; 82(3):542-549. PubMed ID: 28045742
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications.
Shieh WS; Sridhar J; Hong BK; Maguire JI; Rahimy E; Shahlaee A; Ho AC; Hsu J; Regillo CD; Chiang A
Semin Ophthalmol; 2017; 32(5):614-619. PubMed ID: 27367495
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Brown JS; Mahmoud TH
Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
Martínez-Rubio A; Dan GA; Kaski JC
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
[TBL] [Abstract][Full Text] [Related]
6. Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.
Glikson E; Chavkin U; Madgar O; Sagiv D; Nakache G; Yakirevitch A; Wolf M; Alon EE
Laryngoscope; 2019 Jan; 129(1):119-123. PubMed ID: 30325496
[TBL] [Abstract][Full Text] [Related]
7. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
Piccini JP; Garg J; Patel MR; Lokhnygina Y; Goodman SG; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Nessel CC; Mahaffey KW; Singer DE; Califf RM; Fox KA;
Eur Heart J; 2014 Jul; 35(28):1873-80. PubMed ID: 24658769
[TBL] [Abstract][Full Text] [Related]
8. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
Reddy P; Giugliano RP
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.
Ryan A; Saad T; Kirwan C; Keegan DJ; Acheson RW
Clin Exp Ophthalmol; 2013; 41(4):387-95. PubMed ID: 23094982
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
Sennesael AL; Dogné JM; Spinewine A
JAMA Intern Med; 2015 Oct; 175(10):1608-9. PubMed ID: 26237648
[No Abstract] [Full Text] [Related]
11. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
Kham NM; Song M
Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
13. Characteristics, Management, and Outcomes of Patients with Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban.
Burgos KD; Sienko SE; Hoffman JL; Koerber JM; Smythe MA
Clin Appl Thromb Hemost; 2018 Mar; 24(2):372-378. PubMed ID: 28301906
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous splenic rupture due to rivaroxaban.
Nagaraja V; Cranney G; Kushwaha V
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507024
[TBL] [Abstract][Full Text] [Related]
17. A review of oral anticoagulants in patients with atrial fibrillation.
Greenspon AJ
Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy: worth the risk?
Wernly B; Lichtenauer M; Hoppe UC; Lauten A; Navarese EP; Jung C
Minerva Med; 2018 Oct; 109(5):403-405. PubMed ID: 30338683
[No Abstract] [Full Text] [Related]
19. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
20. RECURRENT SUBRETINAL HEMORRHAGE ASSOCIATED WITH RIVAROXABAN ANTICOAGULATION.
Boyce MR; Barth BE; Singh A
Retin Cases Brief Rep; 2016; 10(1):86-8. PubMed ID: 26196651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
